TrialLeukemia2016

A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome.

N Daver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.